$KRRO
Korro Bio, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Cambridge, MA
KRRO chart
What traders are saying about $KRRO
Latest postsKorro Bio, Inc. news
- Citi Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $21
Moomoo ·
- Novo pulls out of accord with Korro Bio
The Pharma Letter ·
- Novo Nordisk walks away from USD 530 million RNA-editing deal with Korro Bio
AllSci ·
- Novo Terminates Research Collaboration With Korro Bio
Pharmaceutical Executive ·
- H.C. Wainwright Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $15
Moomoo ·
- Korro Bio CEO to present at 2026 Jefferies Glob...
Pluang ·
- Korro to Present at the 2026 Jefferies Global Healthcare Conference in London
Yahoo Finance ·
- A medicine developer's CEO is set to present in London on Nov. 19
Stock Titan ·
- Korro Bio 3Q Research and Development Expenses $12.1M >KRRO
Moomoo ·
- Korro Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
marketscreener.com ·
- Korro Bio Begins Phase 1/2 Trial and Receives FDA Designation
TipRanks ·
- Korro Bio Reports Q3 2026 Results with 13.7M Shares Outstanding and Pipeline Updates
Kalkine Media ·
Korro Bio, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $6.4M | $2.3M | $0 | – |
| Net income | -$117.3M | -$83.6M | -$81.2M | -$58.0M |
| Diluted EPS | $-12.48 | $-9.37 | $-53.08 | $-227.42 |
| Total assets (year end) | $113.5M | $226.2M | $221.7M | $73.7M |
| Cash and equivalents (year end) | $21.8M | $55.6M | $166.2M | $36.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Korro Bio, Inc.
- Ticker
- KRRO (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1703647
- Former names
- Frequency Therapeutics, Inc.
Frequently asked questions
What exchange is Korro Bio, Inc. listed on?
Korro Bio, Inc. trades on the Nasdaq under the ticker symbol KRRO.
What industry is Korro Bio, Inc. in?
Korro Bio, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Korro Bio, Inc. headquartered?
Korro Bio, Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Korro Bio, Inc.'s fiscal year end?
Korro Bio, Inc.'s fiscal year ends on December 31.
How much revenue did Korro Bio, Inc. report?
Korro Bio, Inc. reported $6.4M in revenue for calendar year 2025, according to its SEC filings.